Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2014, Article ID 798060, 6 pages
http://dx.doi.org/10.1155/2014/798060
Research Article

Patients with Ankylosing Spondylitis and Low Disease Activity because of Anti-TNF-Alpha Therapy Have Higher TRAIL Levels Than Controls: A Potential Compensatory Effect

1Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, Rheumatology Division, IDIVAL, 39011 Santander, Spain
2Rheumatology Division, Hospital Lucus Augusti, 27003 Lugo, Spain
3Oncology Division, Hospital Del Bierzo, Ponferrada, 24411 León, Spain
4Rheumatology Division, Hospital General de Almansa, 02640 Albacete, Spain
5Department of Epidemiology and Computational Biology, School of Medicine, University of Cantabria, IDIVAL, and CIBER Epidemiología y Salud Pública (CIBERESP), 39011 Santander, Spain
6Cardiology Division, Hospital Lucus Augusti, 27003 Lugo, Spain

Received 9 April 2014; Accepted 9 May 2014; Published 21 May 2014

Academic Editor: Vinod K. Mishra

Copyright © 2014 Fernanda Genre et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Fernanda Genre, Raquel López-Mejías, Javier Rueda-Gotor, et al., “Patients with Ankylosing Spondylitis and Low Disease Activity because of Anti-TNF-Alpha Therapy Have Higher TRAIL Levels Than Controls: A Potential Compensatory Effect,” Mediators of Inflammation, vol. 2014, Article ID 798060, 6 pages, 2014. https://doi.org/10.1155/2014/798060.